I am a new member and this is my first post.
Disclosure: Paushak forms around 5% of my holdings. Buy Price : 605.51
The Net profit for the period of Q1FY17 is the same as that for the Q1FY16 i.e 321 lacs. This seems very strange to me.
Also the profit for FY16 was marginally less that the profit for FY15. From the books I can only see that this is due to the increased Depreciation and expenses(Stores, Spares & Containers consumed and Manufacturing expenses).
Has Paushak hit a plateau and has the growth stalled?
Also I read about drug manufacturers in Europe and America moving away from the Phosgene related drugs. But since Phosgene can only be transported locally and assuming that that is what Paushak does, has there has been some adverse scenario in the Indian market?
There is noting in the annual reports except a mention of competition putting pressure on the prices.
Also if I disregard this years results, the Book Value and Earnings of Paushak sound quite attractive at the current level.
If anyone has any info on any of the above points, kindly do share.
Thank you so much in advance